Dan Suesskind - Israel Corp Independent Director

ILCO Stock  ILA 85,670  1,360  1.61%   

Director

Mr. Dan S. Suesskind serves as Independent Director at Israel Corporation Ltd. since November 23, 2011. He is a member of the Compensation, Finance and Balance Sheets committees. His work experience includes the following roles Chief Financial Officer at Teva Pharmaceutical Industries Ltd. and Director at Migdal Insurance Company, Redhill Biopharma Ltd, Teva Pharmaceutical Industries Ltd., Ness Technologies Ltd. and Syneron Medical Ltd. He has held and holds Directorship at various additional companies. Mr. Suesskind holds a Bachelors degree in Economics and Political Science from The Hebrew University of Jerusalem and a MBA degree from University of Massachusetts, USA. Mr. Suesskind is a member of the Israeli Forum of Chief Financial Officers and was awarded the Life Time Achievement Award from this Forum in 2007. since 2011.
Age 75
Tenure 13 years
Professional MarksMBA
Phone972 3 684 4500
Webhttps://www.israelcorp.com
Suesskind holds a Bachelors degree in Economics and Political Science from The Hebrew University of Jerusalem and a MBA degree from University of Massachusetts.

Israel Corp Management Efficiency

The company has return on total asset (ROA) of 0.1735 % which means that it generated a profit of $0.1735 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.405 %, meaning that it generated $0.405 on every $100 dollars invested by stockholders. Israel Corp's management efficiency ratios could be used to measure how well Israel Corp manages its routine affairs as well as how well it operates its assets and liabilities.
Israel Corp has accumulated 3.54 B in total debt with debt to equity ratio (D/E) of 1.12, which is about average as compared to similar companies. Israel Corp has a current ratio of 1.61, which is within standard range for the sector. Debt can assist Israel Corp until it has trouble settling it off, either with new capital or with free cash flow. So, Israel Corp's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Israel Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Israel to invest in growth at high rates of return. When we think about Israel Corp's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 7 records

DIRECTOR Age

Naama ZeldisOrbit Technologies
56
Yoseph DauberOrbit Technologies
79
Yael AdlerOrbit Technologies
45
Shmuel KleinerOrbit Technologies
70
Gillon BeckOrbit Technologies
56
Avraham ZurOrbit Technologies
58
Ron BenHaimOrbit Technologies
49
Israel Corporation Ltd, together with its subsidiaries, engages in the specialty minerals and chemicals, and refining and petrochemicals businesses in Europe, Asia, North America, South America, and internationally. The company was founded in 1968 and is based in Tel Aviv, Israel. THE ISRAEL operates under Specialty Chemicals classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 1341 people. Israel Corp (ILCO) is traded on Tel Aviv Stock Exchange in Israel and employs 1,332 people.

Management Performance

Israel Corp Leadership Team

Elected by the shareholders, the Israel Corp's board of directors comprises two types of representatives: Israel Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Israel. The board's role is to monitor Israel Corp's management team and ensure that shareholders' interests are well served. Israel Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Israel Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
Amnon Lion, Director
Joshua Rosensweig, External Director
Maya AlschichKaplan, Gen VP
Aviad Kaufman, Chairman of the Board
Dan Suesskind, Independent Director
Yoav Doppelt, Chief Executive Officer
Tali Michaud, Independent Director
Ovadia Eli, Chairman ORL
Yair Caspi, Director
Idan Hizki, Sr Relations
Jacob Amidror, External & Independent Director
Asher Grinbaum, COO Ltd
Maya Kaplan, Executive Vice President, General Counsel, Company Secretary
Shay Ohayon, Controller
Ofer Alkalay, Internal Auditor
Sagi Kabla, Vice President - Finance

Israel Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Israel Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Israel Stock

Israel Corp financial ratios help investors to determine whether Israel Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Israel with respect to the benefits of owning Israel Corp security.